Janet Hammond
Förmögenhet: 683 008 $ per 2026-08-31
Förmögenhet: 683 008 $ per 2026-08-31
Janet Hammond is currently Director at Enterprise Therapeutics Ltd. since 2024, Chief Development Officer at Atea Pharmaceuticals, Inc. since 2020, and Vice President-Translational Medicine at Roche Ltd. since 2011.
Former positions include Group Director-Virology Clinical Research at Bristol Myers Squibb Co., Chief Medical Officer, SVP & Head-Medical Affairs at Bausch Health Americas, Inc., SVP & Head-China Infectious Disease at F.
Hoffmann-La Roche Ltd. from 2011 to 2016, Chief Medical Officer, SVP & Head-Medical Affairs at Valeant Pharmaceutical, VP, Head-General Medicine & Infectious Disease at AbbVie, Inc. from 2016 to 2020, Head-Clinical Discovery at GSK Plc, and Senior Clinical Research Physician at Glaxo Wellcome, Inc. Education includes a doctorate from the University of Cape Town and graduate studies at Johns Hopkins Bloomberg School of Public Health.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-04-24 | 127 665 ( 0,16 % ) | 683 008 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| ATEA PHARMACEUTICALS, INC. | Företagsledare/Principal | 2020-08-01 |
Roche Ltd.
Roche Ltd. Financial ConglomeratesFinance Provides investment services | Företagsledare/Principal | 2011-03-29 |
Enterprise Therapeutics Ltd.
Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Develops novel therapies to patients suffering with respiratory diseases | Direktör/Styrelseledamot | 2024-05-01 |
| Företag | Position | Slut |
|---|---|---|
| ABBVIE INC. | Företagsledare/Principal | 2020-08-01 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Företagsledare/Principal | 2016-11-01 |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Teknisk/Vetenskaplig/F&U Direktör | 2011-09-12 |
Valeant Pharmaceutical | Teknisk/Vetenskaplig/F&U Direktör | - |
| BRISTOL-MYERS SQUIBB COMPANY | Teknisk/Vetenskaplig/F&U Direktör | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 12 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Bausch Health Americas, Inc.
Bausch Health Americas, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals | Health Technology |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
AbbVie, Inc.
AbbVie, Inc. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufacturing, commercialization & sale of immunology medicines and therapies | Health Technology |
Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes antiviral therapeutics | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Cape Town
University of Cape Town Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roche Ltd.
Roche Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
Glaxo Wellcome, Inc.
Glaxo Wellcome, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical preparations | Health Technology |
Johns Hopkins Bloomberg School of Public Health
Johns Hopkins Bloomberg School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Enterprise Therapeutics Ltd.
Enterprise Therapeutics Ltd. BiotechnologyHealth Technology Develops novel therapies to patients suffering with respiratory diseases | Health Technology |
Valeant Pharmaceutical |
Välj din utgåva
All finansiell information anpassad till den nationella nivån